Biliary Tract Cancers (BTCs) Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Biliary Tract Cancers (BTCs) Market is segmented By Treatment (Chemotherapy (Platinum-based Agents, Fluoropyrimidines, Gemcitabine), Targeted Therapy (Tyrosine Kinase Inhibitors, FGFR Inhibitors), Immunotherapy (PD-1/PD-L1 Inhibitors, Radiation Therapy)), By Cancer Type (Intrahepatic Bile Duct Cancer, Extrahepatic Bile Duct Cancer, Gallbladder Cancer), By Distribution Channel (Hospitals, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.

Biliary Tract Cancers (BTCs) Market is segmented By Treatment (Chemotherapy (Platinum-based Agents, Fluoropyrimidines, Gemcitabine), Targeted Therapy ....

Biliary Tract Cancers (BTCs) Market Size

Market Size in USD

CAGR5.5%

Study Period	2024 - 2031
Base Year of Estimation	2023
CAGR	5.5%
Market Concentration	Medium
Major Players	Roche Holding AG, Merck & Co., Inc., AstraZeneca plc, Bristol Myers Squibb Company, Novartis AG

*Disclaimer: Major players are listed in no particular order.

*Source: Coherent Market Insights

Want to purchase customized report?
please let us know !

Biliary Tract Cancers (BTCs) Market Analysis

The biliary tract cancers (BTCs) market is estimated to be valued at USD 0.822 billion in 2024 and is expected to reach USD 1.196 billion by 2031, growing at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2031. The increasing prevalence of biliary tract cancers such as gallbladder and bile duct cancers due to changing lifestyle patterns and rising geriatric population is driving the growth of this market.

Biliary Tract Cancers (BTCs) Market Report Snapshots

Buy Now